136 related articles for article (PubMed ID: 16192738)
1. Efficient short-term control of hypercortisolaemia by low-dose etomidate in severe paediatric Cushing's disease.
Greening JE; Brain CE; Perry LA; Mushtaq I; Sales Marques J; Grossman AB; Savage MO
Horm Res; 2005; 64(3):140-3. PubMed ID: 16192738
[TBL] [Abstract][Full Text] [Related]
2. A novel use of etomidate for intentional adrenal suppression to control severe hypercortisolemia in childhood.
Mettauer N; Brierley J
Pediatr Crit Care Med; 2009 May; 10(3):e37-40. PubMed ID: 19433940
[TBL] [Abstract][Full Text] [Related]
3. Use of intravenous etomidate to control acute psychosis induced by the hypercortisolaemia in severe paediatric Cushing's disease.
Chan LF; Vaidya M; Westphal B; Allgrove J; Martin L; Afshar F; Hindmarsh PC; Savage MO; Grossman AB; Storr HL
Horm Res Paediatr; 2011; 75(6):441-6. PubMed ID: 21430362
[TBL] [Abstract][Full Text] [Related]
4. Etomidate infusion in the critical care setting for suppressing the acute phase of Cushing's syndrome.
Dabbagh A; Sa'adat N; Heidari Z
Anesth Analg; 2009 Jan; 108(1):238-9. PubMed ID: 19095856
[TBL] [Abstract][Full Text] [Related]
5. Nonhypnotic low-dose etomidate for rapid correction of hypercortisolaemia in Cushing's syndrome.
Allolio B; Schulte HM; Kaulen D; Reincke M; Jaursch-Hancke C; Winkelmann W
Klin Wochenschr; 1988 Apr; 66(8):361-4. PubMed ID: 3392892
[TBL] [Abstract][Full Text] [Related]
6. Infusion of low dose etomidate: correction of hypercortisolemia in patients with Cushing's syndrome and dose-response relationship in normal subjects.
Schulte HM; Benker G; Reinwein D; Sippell WG; Allolio B
J Clin Endocrinol Metab; 1990 May; 70(5):1426-30. PubMed ID: 2159485
[TBL] [Abstract][Full Text] [Related]
7. Mitotane, metyrapone, and ketoconazole combination therapy as an alternative to rescue adrenalectomy for severe ACTH-dependent Cushing's syndrome.
Kamenický P; Droumaguet C; Salenave S; Blanchard A; Jublanc C; Gautier JF; Brailly-Tabard S; Leboulleux S; Schlumberger M; Baudin E; Chanson P; Young J
J Clin Endocrinol Metab; 2011 Sep; 96(9):2796-804. PubMed ID: 21752886
[TBL] [Abstract][Full Text] [Related]
8. Medical treatment of Cushing's syndrome: adrenal-blocking drugs and ketaconazole.
Feelders RA; Hofland LJ; de Herder WW
Neuroendocrinology; 2010; 92 Suppl 1():111-5. PubMed ID: 20829630
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic Strategies for the Treatment of Severe Cushing's Syndrome.
Alexandraki KI; Grossman AB
Drugs; 2016 Mar; 76(4):447-58. PubMed ID: 26833215
[TBL] [Abstract][Full Text] [Related]
10. Etomidate use for Cushing's syndrome caused by an ectopic adrenocorticotropic hormone-producing tumor.
Johnson TN; Canada TW
Ann Pharmacother; 2007 Feb; 41(2):350-3. PubMed ID: 17213295
[TBL] [Abstract][Full Text] [Related]
11. Clinical features, diagnosis, treatment and molecular studies in paediatric Cushing's syndrome due to primary nodular adrenocortical hyperplasia.
Storr HL; Mitchell H; Swords FM; Main KM; Hindmarsh PC; Betts PR; Shaw NJ; Johnston DI; Clark AJ; Reznek RH; Grossman AB; Savage MO
Clin Endocrinol (Oxf); 2004 Nov; 61(5):553-9. PubMed ID: 15521956
[TBL] [Abstract][Full Text] [Related]
12. The medical management of Cushing's syndrome during pregnancy.
Lim WH; Torpy DJ; Jeffries WS
Eur J Obstet Gynecol Reprod Biol; 2013 May; 168(1):1-6. PubMed ID: 23305861
[TBL] [Abstract][Full Text] [Related]
13. Etomidate in the management of hypercortisolaemia in Cushing's syndrome: a review.
Preda VA; Sen J; Karavitaki N; Grossman AB
Eur J Endocrinol; 2012 Aug; 167(2):137-43. PubMed ID: 22577107
[TBL] [Abstract][Full Text] [Related]
14. Long-term remission rates after pituitary surgery for Cushing's disease: the need for long-term surveillance.
Atkinson AB; Kennedy A; Wiggam MI; McCance DR; Sheridan B
Clin Endocrinol (Oxf); 2005 Nov; 63(5):549-59. PubMed ID: 16268808
[TBL] [Abstract][Full Text] [Related]
15. Therapy of Cushing's syndrome with steroid biosynthesis inhibitors.
Engelhardt D; Weber MM
J Steroid Biochem Mol Biol; 1994 Jun; 49(4-6):261-7. PubMed ID: 8043488
[TBL] [Abstract][Full Text] [Related]
16. Emergency and prolonged use of intravenous etomidate to control hypercortisolemia in a patient with Cushing's syndrome and peritonitis.
Drake WM; Perry LA; Hinds CJ; Lowe DG; Reznek RH; Besser GM
J Clin Endocrinol Metab; 1998 Oct; 83(10):3542-4. PubMed ID: 9768661
[TBL] [Abstract][Full Text] [Related]
17. Differential effects of the imidazole derivatives etomidate, ketoconazole and miconazole and of metyrapone on the secretion of cortisol and its precursors by human adrenocortical cells.
Lamberts SW; Bons EG; Bruining HA; de Jong FH
J Pharmacol Exp Ther; 1987 Jan; 240(1):259-64. PubMed ID: 3027305
[TBL] [Abstract][Full Text] [Related]
18. Current therapy of pituitary Cushing's disease.
Pelkonen R
Ann Chir Gynaecol; 1983; 72(3):162-6. PubMed ID: 6625514
[TBL] [Abstract][Full Text] [Related]
19. Use of a parenteral propylene glycol-containing etomidate preparation for the long-term management of ectopic Cushing's syndrome.
Krakoff J; Koch CA; Calis KA; Alexander RH; Nieman LK
J Clin Endocrinol Metab; 2001 Sep; 86(9):4104-8. PubMed ID: 11549633
[TBL] [Abstract][Full Text] [Related]
20. Continuous Etomidate for the Management of Cushing's Syndrome Complicated by Pulmonary Nocardiosis.
Hays WB; Czosnowski Q
J Pharm Pract; 2022 Dec; 35(6):1057-1059. PubMed ID: 34056961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
